Graham Slade recognised in Queen’s Birthday Honours

Graham Slade – Founder of Slade Health and Slade Pharmacy was earlier this month, awarded an AM in the Queen’s Birthday Honours for ‘significant service to the community as a supporter of aged care, medical and multicultural associations and to the pharmacy profession.’ Since founding Slade Pharmacy more than 50 years ago, Graham has been […]

Read more

Innovative new Slade infusion bags to improve medication safety and quality

Slade Health is introducing a new and improved design feature for its infusion bags which will be rolled out for use in hospitals from June 2017. Slade Cytotoxic and Non-Cytotoxic infusion bags which are currently black,, will change to a bold purple and orange colour respectively along with other design features such as large coloured […]

Read more

Slade awarded agreement to supply chemotherapy to South Australia public hospitals

Slade Health has been awarded the SA Health contract to provide chemotherapy compounding services across the state.  The transition of this service is now complete which includes supply to 23 South Australian metro and regional hospitals. Slade currently operates four TGA-licenced manufacturing facilities in Victoria, New South Wales and Queensland, servicing over 200 clinics and […]

Read more

Slade Health broadens into antibiotic compounding with mobiLIFE

Slade Health has acquired the antibiotic compounding business mobiLIFE, including the mobiLIFE compounding facility in Morisset New South Wales. Slade Managing Director, David Slade says the purchase of mobiLIFE’s antibiotic compounding arm adds to Slade Health’s current compounding and TGA-licensed facilities. “This is an exciting time for Slade. We are constantly looking at new and […]

Read more

McBeath Joins Slade Health in NSW

McBeath including its TGA licenced compounding business, has now formally joined Slade Health as part of Icon’s acquisition of McBeath Health Services. Together, Slade and McBeath are committed to delivering the highest standard of specialist patient care and excellence in compounding and pharmacy services to their customers in NSW. Service and supply arrangements currently provided […]

Read more

McBeath Health Services joins Slade Health facilities in NSW

Slade Health (as part of the Icon Consolidated Holdings) has entered into an agreement with McBeath Health Service to re-locate their oncology compounding business to the Slade Health TGA facilities based at Mt Kuring-gai NSW. The business will also include the pharmacy dispensing services currently offered by McBeath which will become part of the Pharmatel […]

Read more

Slade completes its acquisition of the Fresenius Kabi Compounding Business

Slade completes its acquisition of the Fresenius Kabi Compounding Business October 2015 begins a new chapter at Slade. The completion of the acquisition of the Fresenius Kabi Compounding Business realizes Slade’s vision to be a truly national company providing pharmacy and TGA licensed compounding services to patients across Australia. We welcome to Slade our new […]

Read more


Slade has entered into agreements with Fresenius Kabi to purchase its Oncology Compounding Business in Australia. This includes all the TGA licenced compounding facilities in Queensland, New South Wales and Victoria. Slade intends to retain the staff currently employed at the facilities. Slade currently operates a TGA-licenced manufacturing facility in Victoria and services both public […]

Read more
< 1 >